Your browser doesn't support javascript.
loading
Effect of coating excipients on chemical stability of active coated tablets.
Kestur, Umesh; Desai, Divyakant; Zong, Zhixin; Abraham, Anuji; Fiske, John.
Afiliación
  • Kestur U; Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, NJ, USA.
  • Desai D; Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, NJ, USA.
  • Zong Z; Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, NJ, USA.
  • Abraham A; Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, NJ, USA.
  • Fiske J; Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, NJ, USA.
Pharm Dev Technol ; 26(1): 41-47, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33021427
The objective of this study was to understand the impact of coating excipients on the chemical stability of active pan coated peliglitazar, which was prone to acid as well as base-catalyzed degradation. Four different coating formulations containing either polyvinyl alcohol (PVA) or hydroxypropyl methylcellulose (HPMC) as a coating polymer and triacetin (glycerol triacetate) or polyethylene glycol (PEG) as a plasticizer/detackifier were used for coating of peliglitazar in a perforated pan coater. Tablets of one-milligram strength were manufactured by suspending the drug in the coating suspension and spray coating onto inert core tablets. The active coated tablets were placed on stability (40 °C/75% RH) in high-density polyethylene (HDPE) bottles in closed condition with desiccants or in open condition. Tablet samples were withdrawn and analyzed for degradants using a stability-indicating HPLC method. The overall stability for the film-forming polymer-plasticizer/detackifier combination showed the rank order: HPMC-triacetin > PVA-triacetin > HPMC-PEG > PVA-PEG. Higher stability of triacetin systems over PEG systems was attributed to lower solubility of peliglitazar in triacetin coating systems. For the same plasticizer/detackifier, higher stability of HPMC over PVA-based formulations was attributed to lower solubility and mobility of peliglitazar in HPMC compared with the PVA-based coating.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Comprimidos Recubiertos / Química Farmacéutica / Excipientes Idioma: En Revista: Pharm Dev Technol Asunto de la revista: FARMACIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Comprimidos Recubiertos / Química Farmacéutica / Excipientes Idioma: En Revista: Pharm Dev Technol Asunto de la revista: FARMACIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos